In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...
The Associated Press on MSN15d
Newsom committed California to making its own insulin. It’s at least a year behind his scheduleCalifornia is not one of those states. Newsom in October rejected a $35 monthly insulin copay cap. In his veto message, he cited the state’s $100 million investment in insulin production as an example ...
the brand name insulin glargine, without needing a separate prescription. The length of time it takes for a company to develop a drug, get FDA approval and bring it to market is highly variable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback